What Else Can Cause Hair Loss During Weight Loss
References: Wegovy (semaglutide) injection, for subcutaneous use
7% of people taking Wegovy (92 people) left the medical study due to side effects, compared to 3.1% of people taking placebo (20 people)
Routine discussion at your next scheduled appointment is appropriate for mild injection site reactions that resolve within a few days, minor itching without rash that is intermittent and tolerable, or gradual skin texture changes that may be related to weight loss
While these findings are promising, it is important to note that most of the research on semaglutide and inflammation has focused on general inflammation in the body rather than specifically on back pain
identified the expression of Toll-like receptors (TLRs) and interferon receptors (IFN) in TRCs, which, upon activation, trigger apoptosis and disrupt cellular balance in taste buds